Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post-Bariatric Hypoglycemia: early-phase trial registry
2 of 5 indexed Post-Bariatric Hypoglycemia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Post-Bariatric Hypoglycemia: 5 US clinical trials tracked, 2 recruiting.
Post-Bariatric Hypoglycemia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Amylyx Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition post-bariatric-hypoglycemia
OPEN 2 | RECR 40% | LATE 1 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Post-Bariatric Hypoglycemia lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Post-Bariatric Hypoglycemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Post-Bariatric Hypoglycemia is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Post-Bariatric Hypoglycemia research.
Amylyx Pharmaceuticals accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Post-Bariatric Hypoglycemia trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Post-Bariatric Hypoglycemia research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia
Stanford University
NCT04615546
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
MBX Biosciences
NCT07029412
Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia
Recordati Group
NCT05928390
Avexitide for Treatment of Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals
NCT06747468
The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia
Joslin Diabetes Center
NCT05560789
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Post-Bariatric Hypoglycemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Post-Bariatric Hypoglycemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Post-Bariatric Hypoglycemia page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Post-Bariatric Hypoglycemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Amylyx Pharmaceuticals sponsors the most Post-Bariatric Hypoglycemia trials on record, review their full trial history before evaluating a specific study. See Amylyx Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post-Bariatric Hypoglycemia condition card totals 5 registered trials; most-linked intervention Physical activity (cycling on a stationary bicycle ergometer or walking on a treadmill); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.